PRICARA®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc
  • Home
  • Innovation & Research
  • News Center
  • Contact Us
  • Tell a Friend
  • Global Resources
  • Sitemap
  • Printer-friendly
  • TextSize SMALL MEDIUM LARGE SMALL
  • Legal Notice
  • Privacy Policy
  • State Regulations

Following are recent news releases issued by PriCara®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

For additional media resources, click here.

07/19/10
PHASE 3 OPEN-LABEL STUDY COMPARING TAPENTADOL EXTENDED RELEASE TABLETS TO OXYCODONE CONTROLLED RELEASE TABLETS PUBLISHED BY PAIN
05/07/10
DATA COMPARING NUCYNTA® (TAPENTADOL) TABLETS TO OXYCODONE IMMEDIATE RELEASE TABLETS PRESENTED AT 2010 AMERICAN PA
05/03/10
TAPENTADOL DATA TO BE PRESENTED AT 2010 AMERICAN PAIN SOCIETY ANNUAL MEETING
01/14/10
PRICARA® is dedicated to Primary Care - helping healthcare professionals meet their patients' needs. It's called Health Care
06/23/09
NUCYNTA™ (TAPENTADOL) CII IMMEDIATE RELEASE TABLETS NOW AVAILABLE FOR RELIEF OF MODERATE TO SEVERE ACUTE PAIN
05/07/09
THREE CLINICAL PRESENTATIONS ON TAPENTADOL EXTENDED RELEASE TABLETS FOR CHRONIC PAIN FEATURED AT 2009 AMERICAN PAIN SOCIETY ANNU
05/06/09
Dr. Drew Joins Forces with PriCara® and the National Association of School Nurses in Program to Prevent Prescript
12/31/08
PRICARA® RECALLS 50 mcg/hr DURAGESIC® (fentanyl transdermal system) CII PAIN PATCHES
11/21/08
FDA Approves TAPENTADOL Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain
© Ortho-McNeil-Janssen Pharmaceuticals, Inc. 2005-2010. All rights reserved.

Your use of the information on this site is subject to the terms of our Legal Notice. Please see our Privacy Policy.

This site is published by PriCara®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, which is solely responsible for its contents.

This information is intended for the use of our customers, patients and healthcare professionals in the United States only. PriCara® recognizes that the Internet is a global communications medium; however, laws, regulatory requirements and medical practices for pharmaceutical products vary from country to country. The Prescribing Information included here may not be appropriate for use outside of the United States. Capitalized product names are trademarks of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

This page was last modified on: Jul 20 2010 at 13:49:52 EDT